Search 

Meet Axol Bioscience at the UK Pavilion (Hall B, Stand 2348).

We support your pursuit of more effective, safer therapies. Like you, we believe that having more human-relevant disease models will expand scientificknowledge and de-risk drug development. We usehuman iPSCs to achieve this and have been doingso since 2006.We use donated cells from patients and iPSC technology to build physiologically relevant in vitromodels.

We have a special focus on neurodegenerative diseases like Alzheimer’s disease as well ascardiotoxicity to promote drug safety. When working with candidate compounds or novel therapies, our in vitro platforms give you betterearlier-stage modeling and safety testing and later-stage efficacy evaluation and improved patientselection.

With these data comes better insights, helping you de-risk projects, reduce costs, and save timeduring drug development.At Axol Bioscience, we help your science with better models of human disease.